← Leaderboards
Lynn Bry
Brigham And Women'S Hospital
$10,918,358
Attributed
$11,882,662
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,882,662 · 10
By mechanism
R01$7,882,753 · 4
P30$2,993,529 · 3
K08$503,280 · 1
R21$324,100 · 1
R03$179,000 · 1
Top collaborators
- Nicholas J Mantis6 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Sophia Koo$15,534,982
- Meir J Stampfer$56,174,887
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesComplexIn VivoPathogenResearch PersonnelGnotobioticTissuesProductionEpithelialMicrobiotaMemberFermentationMetabolicMolecularIn VitroGerm-FreeInfectionToxinNutrientGrowthLaboratoriesSourceAffectArea
Grant awards (34)
Harnessing commensal redox metabolism in infection prevention$849,858
R01 · FY2025 · AI · contact PI
Commensal control of C. difficile virulence$603,478
R01 · FY2025 · AI · contact PI
Harnessing commensal redox metabolism in infection prevention$841,796
R01 · FY2024 · AI · contact PI
Commensal control of C. difficile virulence$673,670
R01 · FY2024 · AI · contact PI
NMR-resolved dynamics of C. difficile metabolism$89,500
R03 · FY2024 · AI · contact PI
Commensal control of C. difficile virulence$673,670
R01 · FY2023 · AI · contact PI
NMR-resolved dynamics of C. difficile metabolism$89,500
R03 · FY2023 · AI · contact PI
Commensal control of C. difficile virulence$673,670
R01 · FY2022 · AI · contact PI
Gnotobiotics, Microbiology and Metagenomics Core$277,496
P30 · FY2022 · DK · contact PI
Commensal control of C. difficile virulence$748,420
R01 · FY2021 · AI · contact PI
Gnotobiotics, Microbiology and Metagenomics Core$315,996
P30 · FY2021 · DK · contact PI
Gnotobiotic, Microbiology and Metagenonomics$343,706
P30 · FY2020 · DK · contact PI
Gnotobiotic, Microbiology and Metagenonomics$308,458
P30 · FY2019 · DK · contact PI
Gnotobiotic, Microbiology and Metagenonomics$345,176
P30 · FY2018 · DK · contact PI
Gnotobiotic, Microbiology and Metagenonomics$342,412
P30 · FY2017 · DK · contact PI
Gnotobiotic, Microbiology and Metagenonomics$344,143
P30 · FY2016 · DK · contact PI
GNOTOBIOTICS AND MICROBIOLOGY CORE$156,299
P30 · FY2015 · DK · contact PI
GNOTOBIOTICS AND MICROBIOLOGY CORE$216,326
P30 · FY2014 · DK · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$373,283
R01 · FY2013 · HD
GNOTOBIOTICS AND MICROBIOLOGY CORE$164,559
P30 · FY2013 · DK · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$411,044
R01 · FY2012 · HD
GNOTOBIOTICS AND MICROBIOLOGY CORE$178,958
P30 · FY2012 · DK · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$412,584
R01 · FY2011 · HD
Epithelial Glycoconjugates as Barriers against Enteric Infections$33,051
R01 · FY2011 · HD
Crimson - i2b2 integration for high-throughput, scalable sample collection$445,000
R01 · FY2010 · LM · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$349,296
R01 · FY2010 · HD
Crimson - i2b2 integration for high-throughput, scalable sample collection$444,583
R01 · FY2009 · LM · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$349,350
R01 · FY2009 · HD
Role of T cells in self-limited mucosal infections$128,520
K08 · FY2006 · AI · contact PI
Protective role of cross-reactive anti-enteric antibody$162,050
R21 · FY2005 · AI
Role of T cells in self-limited mucosal infections$128,520
K08 · FY2005 · AI
Protective role of cross-reactive anti-enteric antibody$162,050
R21 · FY2004 · AI
Role of T cells in self-limited mucosal infections$128,520
K08 · FY2004 · AI
Role of T cells in self-limited mucosal infections$117,720
K08 · FY2003 · AI